Kayawell Clinical Research Academy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -63.43%
- Ebitda 50.00%
- Net Worth
- Total Assets -3.77%
About Kayawell Clinical Research Academy
Kayawell Clinical Research Academy Private Limited (KCRAPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2019 (Five years and 11 months 4 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manisha Agrawal and Sugan Gupta serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999RJ2019PTC064256
-
Company No.
064256
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Kayawell Clinical Research Academy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manisha Agrawal
|
Director | 12-Mar-2019 | Current |
|
Sugan Gupta
|
Director | 12-Mar-2019 | Current |
Financial Performance of Kayawell Clinical Research Academy.
Kayawell Clinical Research Academy Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 63.43% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kayawell Clinical Research Academy?
Unlock access to Kayawell Clinical Research Academy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Dream Soft4u Private LimitedManisha Agrawal is a mutual person
-
Kayawell Lifecare Private LimitedManisha Agrawal is a mutual person
-
Gingerbirds Private Limited
Sugan Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kayawell Clinical Research Academy?
Unlock and access historical data on people associated with Kayawell Clinical Research Academy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kayawell Clinical Research Academy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kayawell Clinical Research Academy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.